All the news Showing 10 of 13 articles from: HBV treatment for people with HIVGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Biktarvy combination pill may be most effective option for people with HIV and hepatitis B Liz Highleyman / 03 August 2022 Although two antiretroviral drug regimens proved about equally effective at suppressing HIV, the Biktarvy combination pill (bictegravir, emtricitabine and tenofovir alafenamide) did a better job suppressing hepatitis B virus (HBV) ... Hepatitis B treatment for all who need it an "achievable public health goal" for Malawi Keith Alcorn / 13 December 2021 Providing hepatitis B treatment for everyone who needs it in Malawi is an achievable public health goal, researchers from the Malawi-Liverpool-Wellcome Trust programme report, following community surveys in Blantyre, Malawi. Hepatitis B treatment ... People with HIV and hepatitis B should have ongoing monitoring for liver cancer Liz Highleyman / 15 March 2021 People with HIV and hepatitis B co-infection remain at risk for developing hepatocellular carcinoma (HCC) despite antiviral treatment and should undergo regular monitoring for liver cancer, according to research presented ... Hepatitis B treatment suboptimal in people with HIV in Africa Keith Alcorn / 04 February 2020 Testing for chronic hepatitis B infection was very low in people living with HIV in Cameroon, a country with a high burden of hepatitis B, and suppression of hepatitis B virus was ... Ongoing hepatitis B virus replication associated with higher mortality for people with HIV Liz Highleyman / 11 August 2016 People with HIV and hepatitis B virus (HBV) co-infection have more than double the risk of death if they have ongoing high-level HBV replication, indicating a need for prompt treatment, according to an ... HIV/HBV co-infection linked to worse immune recovery and death, but tenofovir improves outcomes Liz Highleyman / 12 April 2016 HIV-positive people with hepatitis B virus (HBV) co-infection had impaired CD4 cell recovery after starting antiretroviral therapy (ART) and a higher risk of death than those without hepatitis B, but use of ... Tenofovir is highly effective for HIV/HBV co-infection, meta-analysis shows Liz Highleyman / 03 September 2013 Tenofovir, which has potent activity against both HIV and hepatitis B virus (HBV), is the most effective hepatitis B treatment for people with HIV and HBV co-infection, according to a 23-study meta-analysis ... Combining tenofovir with FTC or 3TC boosts chances of HBV suppression for people co-infected with HIV Michael Carter / 19 February 2013 A study involving people co-infected with HIV and hepatitis B virus (HBV) shows that antiretroviral therapy that combines tenofovir with FTC or 3TC has the best chance of suppressing HBV replication to undetectable ... Switching to tenofovir suppresses hepatitis B in HIV/HBV co-infected people Liz Highleyman / 20 September 2012 People with HIV and hepatitis B virus (HBV) co-infection, who substituted tenofovir (Viread) for zidovudine (Retrovir) or abacavir (Ziagen) in their antiretroviral regimen, saw a reduction in hepatitis B viral load despite HBV ... Hepatitis B genotype B associated with poorer liver-related outcomes in Taiwanese patients co-infected with HIV and hepatitis B Michael Carter / 13 December 2011 Liver-related outcomes are poorer in HIV-positive patients who are co-infected with hepatitis B virus genotype B compared to co-infected patients with hepatitis B genotype C, Taiwanese investigators report in the online edition of ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive